Phase 1
Completed N=26
Harnessing the Power of Technology: MOMBA for Postpartum Smoking
Source: ClinicalTrials.gov NCT02237898 ↗Enrolled (actual)
26
Serious AEs
0.0%
Results posted
May 2020
Primary outcomePrimary: Acceptability — 0; 0; 1; 0 Participants
Summary
Through a smartphone platform, financial incentives for smoking abstinence in postpartum women can be delivered remotely, thus minimizing the need for participants to come to the office to receive traditional contingency management.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Acceptability |
0; 0; 1; 0; 0; 0 | — |
| PRIMARY Enrollment Rate |
26 | — |
| PRIMARY Remote Detection |
0.93; 0.87; 0.76; 0.66; 0.81; 0.67 | — |
| PRIMARY Retention: Number of Participants Remaining in Study at 12 Weeks |
7; 2 | — |
| PRIMARY Visit Attendance / Challenge Completion |
16; 21.5 | 0.3 |
| SECONDARY Number of Participants With Short Term Abstinence From Smoking |
2; 2; 3; 2; 3; 1 | — |
| SECONDARY Number of Participants With Long Term Abstinence From Smoking at 9 Month Follow-Up |
2; 2; 3; 3; 1; 0 | — |
| SECONDARY Number of Participants With Long Term Abstinence From Smoking at 15 Month Follow-Up |
3; 4; 3; 4; 1; 0 | — |
Eligibility Criteria
Inclusion Criteria
- Women who are over the age of 18
- Speak English
- Second or third trimester of pregnancy
- Smoking in the third trimester of pregnancy
- No complicating general medical or psychiatric conditions (including marijuana use).
Exclusion Criteria
- Receiving other smoking cessation medication
- Planning to move out of New Haven in the next 15 months
- Actively suicidal, psychotic or unable to provide informed consent
Data sourced from ClinicalTrials.gov (NCT02237898). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.